4.5 Review

A Review on the Role of Endogenous Neurotrophins and Schwann Cells in Axonal Regeneration

Journal

JOURNAL OF NEUROIMMUNE PHARMACOLOGY
Volume 17, Issue 3-4, Pages 398-408

Publisher

SPRINGER
DOI: 10.1007/s11481-021-10034-3

Keywords

Neurotrophic factors; Schwann cells; Regeneration; Brain-derived neurotrophic factor; Pituitary adenylyl cyclase-activating peptide; Plasticity

Funding

  1. Manipal Academy of Higher Education, Manipal

Ask authors/readers for more resources

Peripheral nerve injuries can be caused by various factors, not just physical trauma. These injuries can lead to a wide range of manifestations and functional impairments, but currently there is no complete recovery option available. Modulating the expression of neurotrophins such as BDNF and PACAP may offer a promising treatment option for nerve injury.
Injury to the peripheral nerve is traditionally referred to acquired nerve injury as they are the result of physical trauma due to laceration, stretch, crush and compression of nerves. However, peripheral nerve injury may not be completely limited to acquired physical trauma. Peripheral nerve injury equally implies clinical conditions like Guillain-Barre syndrome (GBS), Carpal tunnel syndrome, rheumatoid arthritis and diabetes. Physical trauma is commonly mono-neuropathic as it engages a single nerve and produces focal damage, while in the context of pathological conditions the damage is divergent involving a group of the nerve causing polyneuropathy. Damage to the peripheral nerve can cause a diverse range of manifestations from sensory impairment to loss of function with unpredictable recovery patterns. Presently no treatment option provides complete or functional recovery in nerve injury, as nerve cells are highly differentiated and inert to regeneration. However, the regenerative phenotypes in Schwann cells get expressed when a signalling cascade is triggered by neurotrophins. Neurotrophins are one of the promising biomolecules that are released naturally post-injury with the potential to exhibit better functional recovery. Pharmacological intervention modulating the expression of these neurotrophins such as brain-derived neurotrophic factor (BDNF) and pituitary adenylyl cyclase-activating peptide (PACAP) can prove to be a significant treatment option as endogenous compounds which may have remarkable innate advantage showing maximum 'biological relevance'.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available